- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 225/08 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with two six-membered rings
Patent holdings for IPC class C07D 225/08
Total number of patents in this class: 54
10-year publication summary
5
|
2
|
5
|
3
|
3
|
1
|
2
|
4
|
5
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Innate Pharma S.A. | 103 |
6 |
SynAffix B.V. | 98 |
6 |
Paul Scherrer Institut | 299 |
5 |
University of Georgia Research Foundation, Inc. | 1004 |
5 |
Bristol-myers Squibb Company | 4865 |
2 |
F. Hoffmann-La Roche AG | 7938 |
2 |
Roche Diagnostics Operations, Inc. | 1431 |
2 |
Life Technologies Corporation | 3207 |
2 |
Cancer Targeted Technology LLC | 25 |
2 |
University of Connecticut | 815 |
2 |
Roche Diagnostics GmbH | 2702 |
1 |
Ajinomoto Co., Inc. | 2316 |
1 |
ACADIA Pharmaceuticals Inc. | 207 |
1 |
Emory University | 1588 |
1 |
EnVivo Pharmaceuticals, Inc. | 30 |
1 |
Gracel Display Inc. | 26 |
1 |
Hanmi Pharm. Co., Ltd. | 552 |
1 |
MethylGene Inc. | 48 |
1 |
Peking University | 1234 |
1 |
Purdue Pharma L.P. | 512 |
1 |
Other owners | 10 |